Investing Profile

Jeffrey Tong(90)

VCInvestor

Partner at Third Rock Ventures

Your Intro Paths to Jeffrey Tong

Signal uses Gmail to reveal intro paths. Email content is never read.

Jeffrey Tong's investing connections

Connected to 17 investors on Signal.

Networks Jeffrey is a member of

Harvard University Network

805 CONNECTIONS

Harvard University Network

805 CONNECTIONS

Mckinsey & Company Network

613 CONNECTIONS

McKinsey & Company Network

276 CONNECTIONS

Third Rock Ventures Network

50 CONNECTIONS

Find Jeffrey Tong on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$770M

Jeffrey Tong is on these Sector & Stage Rankings

Jeffrey Tong's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Terremoto Biosciences	Series CApr 2026$110M Series BNov 2023$180M Series AMay 2022$75M	$360M
Co-investors: Peter Thompson (OrbiMed), Kevin Koch (OrbiMed), Reid Huber (Third Rock Ventures)
ARTBIO	Series BJul 2025$130M Series ADec 2023$90M	$250M
Co-investors: Robert Mittendorff (B Capital Group), Alexander Pasteur (F-Prime Capital Partners), Maha Katabi (Sofinnova Investments)
Trace Neuroscience	Series ANov 2024$100M	$100M
Co-investors: Anthony Philippakis (GV (Google Ventures)), David Grayzel (Atlas Venture)
Marea Therapeutics	Series BJun 2024$190M Series AJun 2024$65M	$260M
Co-investors: Charles Homcy (Third Rock Ventures), Maha Katabi (Sofinnova Investments), Aaron Royston (venBio), Chris Garabedian (Perceptive Advisors)
Asher Bio	Series CApr 2024$55M Series BSep 2021$110M Series AMar 2021$55M	$220M
Co-investors: Reid Huber (Third Rock Ventures), Jake Simson (RA Capital Management), Alice Zhang (Princeton University Investment Company), Evan Cheng (Mysten Labs)
Septerna	Series BJul 2023$150M Series AJan 2022$100M	$250M
Co-investors: Alan Ezekowitz (Third Rock Ventures), Jeffrey Finer (Third Rock Ventures), Jake Simson (RA Capital Management), Abe Bassan (Samsara BioCapital)
Ambys Medicines	Series ADec 2021$47M Series AAug 2018$60M	$110M
Co-investors: Charles Homcy (Third Rock Ventures)
Takko	SeedN/A$4M	$4M

Jeffrey Tong's Experience

Partner Third Rock Ventures2016 - Present

Consultant Mckinsey & CompanyPresent

Executive Chairman of the Board CelgenePresent

Executive Chairman of the Board Delinia2016 - 2017

Member of the Board of Directors Nora Therapeutics2010 - 2016

President & CEO Nora Therapeutics2010 - 2015

Vice President, Corporate and Product Development Infinity Pharmaceuticals2001 - 2010

Consultant McKinsey & Company2000 - 2001

Jeffrey Tong's Education

Harvard University AB AM, MMS, PhD

Harvard University AB, AM, MMS, PhD AM, MMS, PhD

Investors who invest with Jeffrey Tong

Scouts & Angels Affiliated With Jeffrey Tong